Home
Contact Us
Site Map
Home
> Investor Relations
Investor Relations
News Releases
8/28/2008
King Pharmaceuticals To Present At Thomas Weisel Partners Healthcare Conference
8/27/2008
Pain Therapeutics and King Pharmaceuticals Develop a New Abuse-Resistant Prescription Pain Medication
8/22/2008
King Pharmaceuticals Provides Updated Replay Information for Conference Call Regarding Proposed Acquisition of Alpharma
8/22/2008
King Proposes Acquisition of Alpharma for $33 Per Share in Cash
8/19/2008
Pain Therapeutics and King Pharmaceuticals Announce Final Data of Remoxy Phase III Study at World Pain Congress in Scotland
read more »
Recent Web Casts
9/3/2008 9:10 AM EDT
king pharmaceuticals to present at thomas weisel partners healthcare conference 2008
Home
About Us
Products
Investors
Business Development
Careers
Community
Contact Us
Site Map
Legal
©2000-2008 King Pharmaceuticals,
®
Inc. All rights reserved.
About Us
Vision
Who We Are
Why Choose King?
Strategy
Fast Facts
Products
Avinza® CII
Skelaxin®
Thrombin-JMI®
Altace®
Sonata® CIV
Levoxyl®
Meridian Auto injector Products/EpiPen®
Alphabetic Listing of Products
NDC Listing of Products
Authorized Distributors of Record
Investors
News Releases
Annual Report
SEC Documents
SEC Section 16 Reports
Governance
Webcasts
Business Development
Careers
Job Search
Benefits
Culture and Diversity
Why Choose King?
Locations
Community